New research identifies another gene—beyond BRCA1 and BRCA2 mutations—that may have an effect on breast cancer, one associated with the body’s circadian rhythm.
Oncology is the most advanced area in genomics right now. The field is setting the standard for other indications to follow and improve upon.
Not only are tumours are different from one another, but there can even be genetic differences within a single tumour.
After 10 years of research, a team of Taiwanese scientists have identified a gene that plays a major role in triggering metastasis of cancer cells.
A new chemotherapy regime has proved to shrink tumours twice as fast as in normal methods in patients with aggressive breast cancer carrying a faulty BRCA gene, according to a clinical trial.
Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
AI genomics company Freenome has announced a partnership with proteomics company Biognosys, to enhance its broad-signal approach to early-cancer detection and precision oncology.
Less than half the patients diagnosed with cancer respond favourably to chemotherapy. Now, a new method for testing how patients will respond to various drugs could pave the way for more personalised treatment.
Thermo Fisher Scientific has launched the Oncomine Childhood Cancer Research Assay, a next-generation sequencing panel developed in collaboration with Children’s Hospital Los Angeles.
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.
New data indicates that newly diagnosed lung cancer patients have a 50% increase in survival rate over 1 year when receiving Keytruda over traditional chemotherapy.
Researchers around the globe can now access thousands of paediatric cancer genomic datasets, thanks to a new cloud-based initiative.
Researchers have uncovered a new protein shield that aids in repairing damaged DNA in cells and affects resistance to drugs doctors use to treat breast cancer.